Sleep Europe

- 09/27/2024

Safety and Efficacy of KP1077 in a Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Patients with Idiopathic Hypersomnia

Read More

Sleep Europe

- 09/26/2024

Safety and Efficacy of KP1077 in a Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Patients with Idiopathic Hypersomnia

Read More

SLEEP 2024 Annual Meeting

- 06/03/2024

Safety and Efficacy of KP1077 in a Phase 2, Double-blind, Randomized Trial in Patients With Idiopathic Hypersomnia

Read More

SLEEP 2024 Annual Meeting

- 06/03/2024

Pharmacokinetics of Morning and Nighttime Doses of KP1077, an Investigational Treatment for Idiopathic Hypersomnia

Read More

Beyond Sleepy 2024 Annual Meeting

- 06/01/2024

A Novel Investigational Treatment for Hypersomnia: Where We Are and Where We Need to Go

Read More

Psych Congress 2023

- 09/09/23

Cardiovascular (CV) Safety and Pharmacokinetics (PK) of Serdexmethylphenidate (SDX), a Prodrug of d-Methylphenidate (d-MPH) Compared to Ritalin and Ritalin LA in a Single-Dose Crossover Study in Healthy Volunteers

Read More

Beyond Sleepy 2023 Conference

- 06/04/23

A Clinical Study with KP1077 in Adults with Idiopathic Hypersomnia

Read More